Reversible Sensorineural Hearing Loss with Intravenous Erythromycin Lactobionate
- 1 January 1977
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 86 (1) , 9-11
- https://doi.org/10.1177/000348947708600103
Abstract
Three patients are presented who developed reversible sensorineural hearing losses during treatment with intravenous erythromycin lactobionate. A fourth patient treated with erythromycin gluceptate did not develop hearing loss. Ototoxicity with erythromycin lactobionate has been previously reported in only three patients, one of whom had medication orally. Withdrawal of the antibiotic resulted in prompt improvement in every case with return of hearing to pretreatment levels.Keywords
This publication has 4 references indexed in Scilit:
- Partial Deafness after ErythromycinNew England Journal of Medicine, 1975
- Transient Perceptive Deafness due to Erythromycin LactobionatePublished by American Medical Association (AMA) ,1973
- Ototoxicity of New and Potent Diuretics: A Preliminary StudyJAMA Otolaryngology–Head & Neck Surgery, 1970
- Pathologic Changes in Human Ear After KanamycinJAMA Otolaryngology–Head & Neck Surgery, 1962